InternationalUSRemember you can easily switch between MIP US and MIP International at any time

France: The fight against biopiracy and the Nagoya Protocol




In 1992, the Rio Convention on Biodiversity set the goal of fighting practices known as biopiracy and which are generally seen in developing countries. These involve identifying certain genetic resources of a country and indigenous traditional knowledge that may be linked to their use, developing them, protecting them through patents and extracting commercial gain without any benefit to the indigenous populations in question. The Nagoya Protocol, an extension of the Rio Convention, enshrines a move from mere declarations of intent to concrete measures.

The Nagoya Protocol has been ratified by more than 100 countries, including France and its main goal is to ensure that each member country incorporates into its national law provisions seeking to:

  • make access to genetic resources in its territory, and such traditional knowledge as may be linked thereto, the subject of a system of prior registration or authorisation;
  • ensure that the advantages arising from the use of the said resources and knowledge are indeed shared with indigenous populations.

As far as the European Union is concerned, the principles of the Nagoya Protocol have been incorporated into Regulation 511/2014 and Implementing Regulation 2015/1866. In France, the provisions of the Protocol and the above-mentioned EU Regulations have for the most part been incorporated into the Environmental Code. The latter notably ensures, for all research activity (involving genetic and/or biochemical compositions) concerning genetic resources available in French territory, mandatory compliance with the following formal requirements:

  • filing a declaration prior to accessing any genetic resources with a view to their study, the keeping thereof in a collection or uses thereof not being linked to immediate commercial development;
  • obtaining an authorisation and entering into a contract concerning the sharing of benefits prior to any access to genetic resources with a view to their study and commercial uses thereof, as well as prior to any use of traditional knowledge linked to genetic resources (a specific authorisation and procedure have been laid down to this end).

Furthermore, in cases where there is simultaneous use both of genetic resources and traditional knowledge linked thereto, supplementary reporting obligations are foreseen in the two following cases:

  • for obtaining funding in order to carry out research;
  • for the final development of a product which, if it gives rise to the filing of a patent application, will also result in the requirement to forward to the French Intellectual Property Office (INPI) supplementary information using the form appearing in Annex III of the Implementing Regulation 2015/1866.

It may be noted that the corresponding provisions of the Environmental Code are accompanied by criminal penalties.

Francis Declercq

Cabinet Beau de Loménie
158, rue de l’Université
F - 75340 Paris Cedex 07 France
Tel: +33 1 44 18 89 00
Fax: +33 1 44 18 04 23


Comments






profile

Managing IP

ManagingIP

ManagingIP profile

Here are some photos from our Women in IP Global Network networking event this afternoon at #INTA2018. Thanks to ev… https://t.co/c7XrF5SRZp

May 23 2018 01:54 ·  reply ·  retweet ·  favourite
ManagingIP profile

Our Women in IP Global Network drinks and networking event starts soon! Join us at the Lakefront Ballroom at the Pa… https://t.co/4imxk9x5Z9

May 22 2018 08:30 ·  reply ·  retweet ·  favourite
ManagingIP profile

The travel and leisure panel at #INTA2018 makes its feeling about GDPR clear! https://t.co/lTOXg1YXJi

May 22 2018 06:52 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null

null null null

null null null

May 2018

Technology alters the anti-counterfeiting landscape

Ellie Mertens reveals evolving technologies are changing the counterfeiting game on both sides, as a tool for both prevention and evasion



Most read articles

Supplements